HUP0400222A2 - PDE-4 inhibitort és H1 receptor antagonistát tartalmazó kombináció és ennek alkalmazása tüdőbetegségek kezelésére alkalmas gyógyszerkészítmény előállítására - Google Patents

PDE-4 inhibitort és H1 receptor antagonistát tartalmazó kombináció és ennek alkalmazása tüdőbetegségek kezelésére alkalmas gyógyszerkészítmény előállítására

Info

Publication number
HUP0400222A2
HUP0400222A2 HU0400222A HUP0400222A HUP0400222A2 HU P0400222 A2 HUP0400222 A2 HU P0400222A2 HU 0400222 A HU0400222 A HU 0400222A HU P0400222 A HUP0400222 A HU P0400222A HU P0400222 A2 HUP0400222 A2 HU P0400222A2
Authority
HU
Hungary
Prior art keywords
treatment
receptor antagonist
inhibitor
pde
medicament
Prior art date
Application number
HU0400222A
Other languages
English (en)
Inventor
Richard Graham Knowles
Anthony Terence Nials
Peter Ward
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of HUP0400222A2 publication Critical patent/HUP0400222A2/hu
Publication of HUP0400222A3 publication Critical patent/HUP0400222A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

A találmány pulmonalis betegségeknek, például krónikus obstruktívtüdőbetegségnek (COPD) vagy asztmának egy Hl-receptor antagonistávalkombinált foszfodiészteráz-4 inhibitor beadásával történő kezelésérevonatkozik. A találmány kiterjed a kombináció alkalmazására agyógyszerkészítmények előállítására is. Ó
HU0400222A 2001-06-20 2002-06-17 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases HUP0400222A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0115181.0A GB0115181D0 (en) 2001-06-20 2001-06-20 Novel use
PCT/GB2002/002679 WO2003000289A1 (en) 2001-06-20 2002-06-17 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases

Publications (2)

Publication Number Publication Date
HUP0400222A2 true HUP0400222A2 (hu) 2004-07-28
HUP0400222A3 HUP0400222A3 (en) 2006-02-28

Family

ID=9917074

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400222A HUP0400222A3 (en) 2001-06-20 2002-06-17 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases

Country Status (19)

Country Link
US (1) US20040176419A1 (hu)
EP (1) EP1404369A1 (hu)
JP (1) JP2005501023A (hu)
KR (1) KR20040029323A (hu)
CN (1) CN1518460A (hu)
AR (1) AR035253A1 (hu)
BR (1) BR0210473A (hu)
CA (1) CA2450758A1 (hu)
CO (1) CO5540290A2 (hu)
CZ (1) CZ20033435A3 (hu)
GB (1) GB0115181D0 (hu)
HU (1) HUP0400222A3 (hu)
IL (1) IL159379A0 (hu)
MX (1) MXPA03011702A (hu)
NO (1) NO20035602D0 (hu)
PL (1) PL367622A1 (hu)
RU (1) RU2004101278A (hu)
WO (1) WO2003000289A1 (hu)
ZA (1) ZA200309587B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
TWI347845B (en) 2002-03-06 2011-09-01 Nycomed Gmbh Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20060263350A1 (en) * 2003-09-26 2006-11-23 Fairfield Clinical Trials Llc Combination antihistamine medication
NZ568694A (en) 2005-11-09 2011-09-30 Zalicus Inc Method, compositions, and kits for the treatment of medical conditions
US8207188B2 (en) * 2006-04-07 2012-06-26 Michalis Nicolaou Treatment of diseases modulated by a H4 receptor agonist
TW200902025A (en) * 2007-04-11 2009-01-16 Alcon Res Ltd Use of an inhibitor of TNF α plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
MX2012003693A (es) * 2009-10-01 2012-04-19 Alcon Res Ltd Composiciones de olopatadine y usos de las mismas.
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
AP2015008663A0 (en) 2013-02-19 2015-08-31 Pfizer Azabenzimidazole compounds as inhibitors of PDE4 isozymes for the treatment of cns and other disorders
JP6713982B2 (ja) 2014-07-24 2020-06-24 ファイザー・インク ピラゾロピリミジン化合物
CU20170007A7 (es) 2014-08-06 2017-06-05 Pfizer Compuestos de imidazopiridazina
CN104644584A (zh) * 2015-01-22 2015-05-27 扬子江药业集团有限公司 罗氟司特片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4852561A (en) * 1988-07-27 1989-08-01 Sperry C R Inhalation device
US5990147A (en) * 1997-11-07 1999-11-23 Schering Corporation H3 receptor ligands of the phenyl-alkyl-imidazoles type
DK1041990T3 (da) * 1997-12-23 2006-10-02 Schering Corp Præparat til behandling af respiratoriske sygdomme og hudsygdomme med mindst en leukotrien-antagonist og mindst et antihistamin
BR9804993A (pt) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Composição antialérgica e antiinflamatória
US20020052312A1 (en) * 2000-05-30 2002-05-02 Reiss Theodore F. Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists

Also Published As

Publication number Publication date
CZ20033435A3 (cs) 2004-08-18
NO20035602D0 (no) 2003-12-16
WO2003000289A1 (en) 2003-01-03
KR20040029323A (ko) 2004-04-06
HUP0400222A3 (en) 2006-02-28
RU2004101278A (ru) 2005-02-27
IL159379A0 (en) 2004-06-01
PL367622A1 (en) 2005-03-07
BR0210473A (pt) 2004-08-10
MXPA03011702A (es) 2004-03-19
CN1518460A (zh) 2004-08-04
CO5540290A2 (es) 2005-07-29
EP1404369A1 (en) 2004-04-07
AR035253A1 (es) 2004-05-05
CA2450758A1 (en) 2003-01-03
US20040176419A1 (en) 2004-09-09
ZA200309587B (en) 2005-02-23
GB0115181D0 (en) 2001-08-15
JP2005501023A (ja) 2005-01-13

Similar Documents

Publication Publication Date Title
HUP0400222A2 (hu) PDE-4 inhibitort és H1 receptor antagonistát tartalmazó kombináció és ennek alkalmazása tüdőbetegségek kezelésére alkalmas gyógyszerkészítmény előállítására
HUP0401614A2 (hu) PDE4 inhibitort és antikolinerg hatóanyagot tartalmazó gyógyszerkészítmények és alkalmazásuk
DE602005026007D1 (de) Opioide zur behandlung von chronisch-obstruktiver lungenerkrankung (copd)
BR0316264A (pt) Medicamento para tratamento de doença pulmonar obstrutiva crÈnica
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
ATE381537T1 (de) Formanilid-derivative als beta2-adrenorezeptor- agonisten
HUP0103108A2 (hu) Formoterolt és budesonidot tartalmazó készítmény alkalmazása asztma akut állapotának megelőzésére
CY1108326T1 (el) ΝΕΟΣ ΣΥΝΔΥΑΣΜΟΣ ΑΝΤΙΧΟΛΙΝΕΡΓΙΚΩΝ ΚΑΙ β ΜΙΜΗΤΙΚΩΝ ΓΙΑ ΤΗΝ ΘΕΡΑΠΕΙΑ ΑΝΑΠΝΕΥΣΤΙΚΩΝ ΑΣΘΕΝΕΙΩΝ
ECSP024268A (es) Nuevos polvos para inhalacion que contienen tiotropio
IL160028A (en) Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions comprising them and their use in therapy
GB0324654D0 (en) Medicinal compounds
ECSP055855A (es) Medicamentos en polvo para inhalación que contiene una sal de tiotropio y salmeterolxinafoato
HUP0301447A2 (hu) Tiotrópium- és salmeterolsókat tartalmazó kombinációs gyógyszerkészítmények
NO20065061L (no) Benzoksazin for behandling av sykdommer i luftveiene
EA200970158A1 (ru) Производные хинуклидина в качестве антагонистов м3
NO20061441L (no) Nye tiotropiumsalter, metoder for deres fremstilling, og farmasoytiske formuleringer inneholdende disse
AP2003002909A0 (en) A PDE 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases.
BR0309185A (pt) Medicamento contendo beta-miméticos e um novo anticolinérgico
NO20061440L (no) Metode fo fremstilling av tiotropiumsalter og farmasoytiske formuleringer inneholdende samme.
MX2021000456A (es) Compuesto triciclico fusionado como inhibidor dual pde3/pde4.
MXPA04002401A (es) Nuevos medicamentos para inhalacion.
MEP51608A (en) Pulverulent formulation for inhalation containing tiotropium
DE60206391D1 (de) Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen
DK1581224T3 (da) Tiotropiumholdig lægemiddelsammensætning til inhalation
HUP0300032A2 (en) Use of compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoreceptor for preparation of pharmaceutical composition

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished